Information Provided By:
Fly News Breaks for February 26, 2020
THC
Feb 26, 2020 | 06:04 EDT
JPMorgan analyst Gary Taylor upgraded Tenet Healthcare to Neutral from Underweight with a price target of $32, up from $31. The analyst cites the company's stronger Q4 free cash flow performance and 26% selloff in the shares over the last two months for the upgrade. While the 2020 hospital and Conifer EBITDA growth guidance were viewed as disappointing, tailwinds seem to be building for Tenet's ambulatory segment, Taylor tells investors in a research note.